---
category: news
title: "Practice-Changing Prostate Cancer Data From ASCO Genitourinary Cancers Symposium 2022"
excerpt: "Prof Bertrand Tombal reports practice-changing data in prostate cancer presented at ASCO-GU 2022, including use of PARP inhibitors plus abiraterone and continuation of enzalutamide after progression"
publishedDateTime: 2022-03-09T15:45:00Z
originalUrl: "https://www.medscape.com/recap/964692"
webUrl: "https://www.medscape.com/recap/964692"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Medscape
  domain: medscape.com

topics:
  - AI in Healthcare
  - AI

secured: "6UpXAIbUrNoaCTHTY4q6NiTaUPz6VAo1SobH6gEKuYcEtjSb7xGQB+lX6QuhEDR246h2tq0mcM66Gtgw7olbqGjNbH9f8B/fiM4AyGlSwpALI4YCH0EwbLto3tBJEhZ5641W+MLisgsRtFqoyhEbLSc98Cjhkc4DXe05B7BRzkMytoN+1ZQheRpaJV5fpx/bjXKD5BAUjl66gSv+3WXokaTdfXaUjnIfQwh4voA89DUIfLoPBblfOHyUy8v6CKowcYm0UDVRlETdny+ZRNHKMX1tB/eZQd5xWem1zHnxTmFf9PKVQ6FAKDeMqaICx9Fvr3JAe5+cT7/XNoKMlOl0IThgke1fLJcBxmJW0T67Upo=;ubFwqsX68+vQEZrJLoFADw=="
---

